Sterling IMRES
Sign in
RecruitingInterventional

Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates

Examining the Efficacy of a Parent-targeted Co-designed Digital Media Intervention to Increase Recruitment Rates Across a Multi-site Randomized Clinical Trial in Canadian NICU's

This is a registered study tracked in the Sterling IMRES research watch. It is sponsored by IWK Health Centre and run by the investigators named in the registry, not by Sterling IMRES. Details come from ClinicalTrials.gov, last updated 16 December 2025.

Summary

WHEAT-Boost is a Study Within A Trial embedded in the WHEAT International Trial in Canadian neonatal units. Families approached about the host trial are randomised to receive a video-based explanation or the usual information. The main measure is the opt-in rate to the host trial.

Objectives

  • Test whether a short digital video increases the proportion of families who agree to join a neonatal trial.
  • Improve how information about research is shared with parents in neonatal intensive care.

Methodology

Study design
Randomized, parallel assignment, open label, primary purpose: other
Conditions
Consent Process
Interventions
Intervention (Video) Arm (behavioral)
Primary outcome
Opt-in Rate for the WHEAT International Trial
Sample size
787 participants (estimated)
Locations
Canada

Team

0

Related research

RecruitingInterventionalPhase 3

Randomised Evaluation of COVID-19 Therapy

University of Oxford

RECOVERY is a large randomised, open-label platform trial led by the University of Oxford that has tested many treatments for patients admitted to hospital with COVID-19, and has since added influenza and community-acquired pneumonia. Its pragmatic design, with minimal data collection and a shared control group, allowed rapid answers, including the finding that dexamethasone reduced deaths. It remains a reference model for efficient trial methodology.

2020
In progressInterventionalPhase 2 / Phase 3

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

Medical Research Council

STAMPEDE is a long-running UK-led platform trial in men with high-risk or metastatic hormone-naive prostate cancer. It has used a multi-arm, multi-stage design to test additions such as docetaxel, abiraterone, zoledronic acid and radiotherapy against standard care, with overall survival as its main outcome. It is widely cited as an example of efficient adaptive trial methodology.

2005